Selected research
Industry Research
Exosome Proteomics Service Industry Research Report 2026
Market perspective
The global Exosome Proteomics Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Exosome Proteomics Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Exosome Proteomics Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Exosome Proteomics Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Exosome Proteomics Service include System Biosciences, HansaBioMed Life Sciences, QIAGEN, Norgen Biotek, Bio-Techne, AMSBIO, NX Pharmagen, Thermo Fisher Scientific and Sistemic, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Exosome Proteomics Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Exosome Proteomics Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Exosome Proteomics Service Market by Company
System Biosciences
HansaBioMed Life Sciences
QIAGEN
Norgen Biotek
Bio-Techne
AMSBIO
NX Pharmagen
Thermo Fisher Scientific
Sistemic
Exosome Diagnostics
Lonza Group
Evox Therapeutics
Evomic Science
Optofluidics
New England Biolabs
Izon Science
Miltenyi Biotec
Codiak BioSciences
Ology Bioservices
Exosome Proteomics Service Segment by Type
Separation
Identification and Characterization
Quantitative Analysis
Content Analysis
Functional Analysis
Exosome Proteomics Service Segment by Application
Financial Industry
Government Sector
Media Organizations
E-commerce and Retail
Others
Exosome Proteomics Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exosome Proteomics Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Exosome Proteomics Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exosome Proteomics Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Exosome Proteomics Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Separation
- Identification and Characterization
- Quantitative Analysis
- Content Analysis
- Functional Analysis
Applications
- Financial Industry
- Government Sector
- Media Organizations
- E-commerce and Retail
- Others
Companies covered
- System Biosciences
- HansaBioMed Life Sciences
- QIAGEN
- Norgen Biotek
- Bio-Techne
- AMSBIO
- NX Pharmagen
- Thermo Fisher Scientific
- Sistemic
- Exosome Diagnostics
- Lonza Group
- Evox Therapeutics
- Evomic Science
- Optofluidics
- New England Biolabs
- Izon Science
- Miltenyi Biotec
- Codiak BioSciences
- Ology Bioservices
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Exosome Proteomics Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Separation
- 2.2.3 Identification and Characterization
- 2.2.4 Quantitative Analysis
- 2.2.5 Content Analysis
- 2.2.6 Functional Analysis
- 2.3 Exosome Proteomics Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Financial Industry
- 2.3.3 Government Sector
- 2.3.4 Media Organizations
- 2.3.5 E-commerce and Retail
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Exosome Proteomics Service Breakdown Data by Type
- 3.1 Global Exosome Proteomics Service Historic Market Size by Type (2021-2026)
- 3.2 Global Exosome Proteomics Service Forecasted Market Size by Type (2027-2032)
4 Exosome Proteomics Service Breakdown Data by Application
- 4.1 Global Exosome Proteomics Service Historic Market Size by Application (2021-2026)
- 4.2 Global Exosome Proteomics Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Exosome Proteomics Service Market Perspective (2021-2032)
- 5.2 Global Exosome Proteomics Service Growth Trends by Region
- 5.2.1 Global Exosome Proteomics Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Exosome Proteomics Service Historic Market Size by Region (2021-2026)
- 5.2.3 Exosome Proteomics Service Forecasted Market Size by Region (2027-2032)
- 5.3 Exosome Proteomics Service Market Dynamics
- 5.3.1 Exosome Proteomics Service Industry Trends
- 5.3.2 Exosome Proteomics Service Market Drivers
- 5.3.3 Exosome Proteomics Service Market Challenges
- 5.3.4 Exosome Proteomics Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Exosome Proteomics Service Players by Revenue
- 6.1.1 Global Top Exosome Proteomics Service Players by Revenue (2021-2026)
- 6.1.2 Global Exosome Proteomics Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Exosome Proteomics Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Exosome Proteomics Service Head Office and Area Served
- 6.4 Global Exosome Proteomics Service Players, Product Type & Application
- 6.5 Global Exosome Proteomics Service Manufacturers Established Date
- 6.6 Global Exosome Proteomics Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Exosome Proteomics Service Market Size (2021-2032)
- 7.2 North America Exosome Proteomics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Exosome Proteomics Service Market Size by Country (2021-2026)
- 7.4 North America Exosome Proteomics Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Exosome Proteomics Service Market Size (2021-2032)
- 8.2 Europe Exosome Proteomics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Exosome Proteomics Service Market Size by Country (2021-2026)
- 8.4 Europe Exosome Proteomics Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Exosome Proteomics Service Market Size (2021-2032)
- 9.2 Asia-Pacific Exosome Proteomics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Exosome Proteomics Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Exosome Proteomics Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Exosome Proteomics Service Market Size (2021-2032)
- 10.2 South America Exosome Proteomics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Exosome Proteomics Service Market Size by Country (2021-2026)
- 10.4 South America Exosome Proteomics Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Exosome Proteomics Service Market Size (2021-2032)
- 11.2 Middle East & Africa Exosome Proteomics Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Exosome Proteomics Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Exosome Proteomics Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 System Biosciences
- 12.1.1 System Biosciences Company Information
- 12.1.2 System Biosciences Business Overview
- 12.1.3 System Biosciences Revenue in Exosome Proteomics Service Business (2021-2026)
- 12.1.4 System Biosciences Exosome Proteomics Service Product Portfolio
- 12.1.5 System Biosciences Recent Developments
- 12.2 HansaBioMed Life Sciences
- 12.2.1 HansaBioMed Life Sciences Company Information
- 12.2.2 HansaBioMed Life Sciences Business Overview
- 12.2.3 HansaBioMed Life Sciences Revenue in Exosome Proteomics Service Business (2021-2026)
- 12.2.4 HansaBioMed Life Sciences Exosome Proteomics Service Product Portfolio
- 12.2.5 HansaBioMed Life Sciences Recent Developments
- 12.3 QIAGEN
- 12.3.1 QIAGEN Company Information
- 12.3.2 QIAGEN Business Overview
- 12.3.3 QIAGEN Revenue in Exosome Proteomics Service Business (2021-2026)
- 12.3.4 QIAGEN Exosome Proteomics Service Product Portfolio
- 12.3.5 QIAGEN Recent Developments
- 12.4 Norgen Biotek
- 12.4.1 Norgen Biotek Company Information
- 12.4.2 Norgen Biotek Business Overview
- 12.4.3 Norgen Biotek Revenue in Exosome Proteomics Service Business (2021-2026)
- 12.4.4 Norgen Biotek Exosome Proteomics Service Product Portfolio
- 12.4.5 Norgen Biotek Recent Developments
- 12.5 Bio-Techne
- 12.5.1 Bio-Techne Company Information
- 12.5.2 Bio-Techne Business Overview
- 12.5.3 Bio-Techne Revenue in Exosome Proteomics Service Business (2021-2026)
- 12.5.4 Bio-Techne Exosome Proteomics Service Product Portfolio
- 12.5.5 Bio-Techne Recent Developments
- 12.6 AMSBIO
- 12.6.1 AMSBIO Company Information
- 12.6.2 AMSBIO Business Overview
- 12.6.3 AMSBIO Revenue in Exosome Proteomics Service Business (2021-2026)
- 12.6.4 AMSBIO Exosome Proteomics Service Product Portfolio
- 12.6.5 AMSBIO Recent Developments
- 12.7 NX Pharmagen
- 12.7.1 NX Pharmagen Company Information
- 12.7.2 NX Pharmagen Business Overview
- 12.7.3 NX Pharmagen Revenue in Exosome Proteomics Service Business (2021-2026)
- 12.7.4 NX Pharmagen Exosome Proteomics Service Product Portfolio
- 12.7.5 NX Pharmagen Recent Developments
- 12.8 Thermo Fisher Scientific
- 12.8.1 Thermo Fisher Scientific Company Information
- 12.8.2 Thermo Fisher Scientific Business Overview
- 12.8.3 Thermo Fisher Scientific Revenue in Exosome Proteomics Service Business (2021-2026)
- 12.8.4 Thermo Fisher Scientific Exosome Proteomics Service Product Portfolio
- 12.8.5 Thermo Fisher Scientific Recent Developments
- 12.9 Sistemic
- 12.9.1 Sistemic Company Information
- 12.9.2 Sistemic Business Overview
- 12.9.3 Sistemic Revenue in Exosome Proteomics Service Business (2021-2026)
- 12.9.4 Sistemic Exosome Proteomics Service Product Portfolio
- 12.9.5 Sistemic Recent Developments
- 12.10 Exosome Diagnostics
- 12.10.1 Exosome Diagnostics Company Information
- 12.10.2 Exosome Diagnostics Business Overview
- 12.10.3 Exosome Diagnostics Revenue in Exosome Proteomics Service Business (2021-2026)
- 12.10.4 Exosome Diagnostics Exosome Proteomics Service Product Portfolio
- 12.10.5 Exosome Diagnostics Recent Developments
- 12.11 Lonza Group
- 12.11.1 Lonza Group Company Information
- 12.11.2 Lonza Group Business Overview
- 12.11.3 Lonza Group Revenue in Exosome Proteomics Service Business (2021-2026)
- 12.11.4 Lonza Group Exosome Proteomics Service Product Portfolio
- 12.11.5 Lonza Group Recent Developments
- 12.12 Evox Therapeutics
- 12.12.1 Evox Therapeutics Company Information
- 12.12.2 Evox Therapeutics Business Overview
- 12.12.3 Evox Therapeutics Revenue in Exosome Proteomics Service Business (2021-2026)
- 12.12.4 Evox Therapeutics Exosome Proteomics Service Product Portfolio
- 12.12.5 Evox Therapeutics Recent Developments
- 12.13 Evomic Science
- 12.13.1 Evomic Science Company Information
- 12.13.2 Evomic Science Business Overview
- 12.13.3 Evomic Science Revenue in Exosome Proteomics Service Business (2021-2026)
- 12.13.4 Evomic Science Exosome Proteomics Service Product Portfolio
- 12.13.5 Evomic Science Recent Developments
- 12.14 Optofluidics
- 12.14.1 Optofluidics Company Information
- 12.14.2 Optofluidics Business Overview
- 12.14.3 Optofluidics Revenue in Exosome Proteomics Service Business (2021-2026)
- 12.14.4 Optofluidics Exosome Proteomics Service Product Portfolio
- 12.14.5 Optofluidics Recent Developments
- 12.15 New England Biolabs
- 12.15.1 New England Biolabs Company Information
- 12.15.2 New England Biolabs Business Overview
- 12.15.3 New England Biolabs Revenue in Exosome Proteomics Service Business (2021-2026)
- 12.15.4 New England Biolabs Exosome Proteomics Service Product Portfolio
- 12.15.5 New England Biolabs Recent Developments
- 12.16 Izon Science
- 12.16.1 Izon Science Company Information
- 12.16.2 Izon Science Business Overview
- 12.16.3 Izon Science Revenue in Exosome Proteomics Service Business (2021-2026)
- 12.16.4 Izon Science Exosome Proteomics Service Product Portfolio
- 12.16.5 Izon Science Recent Developments
- 12.17 Miltenyi Biotec
- 12.17.1 Miltenyi Biotec Company Information
- 12.17.2 Miltenyi Biotec Business Overview
- 12.17.3 Miltenyi Biotec Revenue in Exosome Proteomics Service Business (2021-2026)
- 12.17.4 Miltenyi Biotec Exosome Proteomics Service Product Portfolio
- 12.17.5 Miltenyi Biotec Recent Developments
- 12.18 Codiak BioSciences
- 12.18.1 Codiak BioSciences Company Information
- 12.18.2 Codiak BioSciences Business Overview
- 12.18.3 Codiak BioSciences Revenue in Exosome Proteomics Service Business (2021-2026)
- 12.18.4 Codiak BioSciences Exosome Proteomics Service Product Portfolio
- 12.18.5 Codiak BioSciences Recent Developments
- 12.19 Ology Bioservices
- 12.19.1 Ology Bioservices Company Information
- 12.19.2 Ology Bioservices Business Overview
- 12.19.3 Ology Bioservices Revenue in Exosome Proteomics Service Business (2021-2026)
- 12.19.4 Ology Bioservices Exosome Proteomics Service Product Portfolio
- 12.19.5 Ology Bioservices Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst